| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Combination of GM-CSF with antitumour vaccine strategies
|
Gaudernack, G
|
|
1999
|
35 |
S3 |
p. S33-S35
3 p.
|
artikel
|
| 2 |
Dendritic cells or their exosomes are effective biotherapies of cancer
|
Zitvogel, L
|
|
1999
|
35 |
S3 |
p. S36-S38
3 p.
|
artikel
|
| 3 |
Febrile neutropenia: prophylactic and therapeutic use of GM-CSF
|
Mangi, M.H
|
|
1999
|
35 |
S3 |
p. S4-S7
4 p.
|
artikel
|
| 4 |
GM-CSF and stimulation of monocyte/macrophage function in vivo relevance and in vitro observations
|
Williams, M.A
|
|
1999
|
35 |
S3 |
p. S18-S22
5 p.
|
artikel
|
| 5 |
GM-CSF as adjuvant for immunotherapy with bispecific antibodies
|
Elsässer, D
|
|
1999
|
35 |
S3 |
p. S25-S28
4 p.
|
artikel
|
| 6 |
GM-CSF can cause T cell activation; results of sequential chemo-immunotherapy
|
Groenewegen, G
|
|
1999
|
35 |
S3 |
p. S23-S24
2 p.
|
artikel
|
| 7 |
GM-CSF in haematopoietic stem cell transplantation
|
Croockewit, S
|
|
1999
|
35 |
S3 |
p. S11-S13
3 p.
|
artikel
|
| 8 |
Local low-dose of soluble GM-CSF significantly augments an immune response against tumour antigens in man
|
Mellstedt, H
|
|
1999
|
35 |
S3 |
p. S29-S32
4 p.
|
artikel
|
| 9 |
Local use of GM-CSF for severe mucositis
|
Hejna, M
|
|
1999
|
35 |
S3 |
p. S14-S17
4 p.
|
artikel
|
| 10 |
Molecular aspects of the GM-CSF receptor: an example of the cell signalling mechanisms used by type 1 cytokine receptors
|
Leake, R
|
|
1999
|
35 |
S3 |
p. S2-S3
2 p.
|
artikel
|
| 11 |
[No title]
|
Zwierzina, H.
|
|
1999
|
35 |
S3 |
p. S1-
1 p.
|
artikel
|
| 12 |
Two distinct cell populations are obtained from human blood monocytes cultured with M-CSF, GM-CSF and IL-4
|
Baron, C.L
|
|
1999
|
35 |
S3 |
p. S39-S40
2 p.
|
artikel
|
| 13 |
Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections
|
Jones, T.C
|
|
1999
|
35 |
S3 |
p. S8-S10
3 p.
|
artikel
|
Tijdschrift beschrijving